These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


229 related items for PubMed ID: 3865878

  • 1. Incidence of severe sideeffects during therapy with sulfonylureas and biguanides.
    Berger W.
    Horm Metab Res Suppl; 1985; 15():111-5. PubMed ID: 3865878
    [Abstract] [Full Text] [Related]

  • 2. [Incidence of severe secondary effects during treatment with sulfonylureas and biguanides].
    Berger W.
    Journ Annu Diabetol Hotel Dieu; 1986; ():243-53. PubMed ID: 3613372
    [No Abstract] [Full Text] [Related]

  • 3. Biguanide related lactic acidosis: incidence and risk factors.
    Aguilar C, Reza A, García JE, Rull JA.
    Arch Med Res; 1992; 23(1):19-24. PubMed ID: 1308787
    [Abstract] [Full Text] [Related]

  • 4. All-cause mortality in diabetic patients treated with combinations of sulfonylureas and biguanides.
    Mannucci E, Monami M, Masotti G, Marchionni N.
    Diabetes Metab Res Rev; 2004; 20(1):44-7. PubMed ID: 14737744
    [Abstract] [Full Text] [Related]

  • 5. Metformin: a new treatment option for non-insulin-dependent diabetes mellitus.
    Goo AK, Carson DS, Bjelajac A.
    J Fam Pract; 1996 Jun; 42(6):612-8. PubMed ID: 8656173
    [Abstract] [Full Text] [Related]

  • 6. [The relatively frequent incidence of severe sulfonylurea-induced hypoglycemia in the last 25 years in Switzerland. Results of 2 surveys in Switzerland in 1969 and 1984].
    Berger W, Caduff F, Pasquel M, Rump A.
    Schweiz Med Wochenschr; 1986 Feb 01; 116(5):145-51. PubMed ID: 3961464
    [Abstract] [Full Text] [Related]

  • 7. Metformin and the sulphonylureas: the comparative risk.
    Campbell IW.
    Horm Metab Res Suppl; 1985 Feb 01; 15():105-11. PubMed ID: 3935560
    [Abstract] [Full Text] [Related]

  • 8. Oral antidiabetic therapy in patients with heart disease. A cardiologic standpoint.
    Fisman EZ, Tenenbaum A, Motro M, Adler Y.
    Herz; 2004 May 01; 29(3):290-8. PubMed ID: 15167955
    [Abstract] [Full Text] [Related]

  • 9. Balancing risk and benefit with oral hypoglycemic drugs.
    Hamnvik OP, McMahon GT.
    Mt Sinai J Med; 2009 Jun 01; 76(3):234-43. PubMed ID: 19421967
    [Abstract] [Full Text] [Related]

  • 10. [Antidiabetic biguanides and lactic acidosis].
    Rojas Hidalgo E.
    Rev Clin Esp; 1997 Aug 01; 197(8):568-73. PubMed ID: 9312795
    [No Abstract] [Full Text] [Related]

  • 11. [Adverse effect of biguanides].
    Yamasaki Y, Kuroda A.
    Nihon Rinsho; 2002 Sep 01; 60 Suppl 9():389-92. PubMed ID: 12387023
    [No Abstract] [Full Text] [Related]

  • 12. Comparative tolerability profiles of oral antidiabetic agents.
    Krentz AJ, Ferner RE, Bailey CJ.
    Drug Saf; 1994 Oct 01; 11(4):223-41. PubMed ID: 7848543
    [Abstract] [Full Text] [Related]

  • 13. [The importance of lactate acidosis as a side effect of biguanide therapy].
    Förster H.
    Fortschr Med; 1976 Dec 16; 94(35-36):2065-71. PubMed ID: 1010516
    [Abstract] [Full Text] [Related]

  • 14. Hypoglycemia in hypertensive diabetic patients treated with sulfonylureas, biguanides, and captopril.
    Rett K, Wicklmayr M, Dietze GJ.
    N Engl J Med; 1988 Dec 15; 319(24):1609. PubMed ID: 3059189
    [No Abstract] [Full Text] [Related]

  • 15. [Severe hypoglycemia due to insulin. Risks and adverse effects of antidiabetic drugs].
    Auzepy P, Caquet R.
    Sem Hop; 1983 Mar 10; 59(10):697-705. PubMed ID: 6304892
    [No Abstract] [Full Text] [Related]

  • 16. Oral hypoglycemic agents in type II diabetes mellitus.
    Lubbos H, Miller JL, Rose LI.
    Am Fam Physician; 1995 Nov 15; 52(7):2075-8. PubMed ID: 7484707
    [Abstract] [Full Text] [Related]

  • 17. [The risk of lacticate acidosis: a comparison of the 3 biguanides in treatment of diabetics (authors' transl)].
    Irsigler K, Kritz H, Regal H, Foltin E.
    Wien Klin Wochenschr; 1978 May 12; 90(10):332-7. PubMed ID: 654296
    [Abstract] [Full Text] [Related]

  • 18. Biguanides. Mode of action and role in the up-to-date treatment of diabetes mellitus.
    Fövényi J.
    Ther Hung; 1971 May 12; 19(2):43-8. PubMed ID: 5172874
    [No Abstract] [Full Text] [Related]

  • 19. Metformin associated B12 deficiency.
    Kumthekar AA, Gidwani HV, Kumthekar AB.
    J Assoc Physicians India; 2012 Mar 12; 60():58-60. PubMed ID: 22799121
    [Abstract] [Full Text] [Related]

  • 20. Hypoglycaemia in patients with type 2 diabetes treated with a combination of metformin and sulphonylurea therapy in France.
    Vexiau P, Mavros P, Krishnarajah G, Lyu R, Yin D.
    Diabetes Obes Metab; 2008 Jun 12; 10 Suppl 1():16-24. PubMed ID: 18435670
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.